Our News
-
New Partnership with REGEnLIFE
The director’s board of REGEnLIFE met yesterday in Paris with the Chairman of IGHS Group, Dr. José Alexandre Cunha and the Commercial Counsellor António Sousa to develop...
Read moreNovember 19, 2022 -
The IGHS Group continues its demand for recognition of its work carried out across borders.
Due to the high standards of quality at both technical and human levels that characterise the projects in which the IGHS is involved, an invitation by the Ministry of Health of Uzbekistan to participate in meetings was extended to our group.
Read moreNovember 18, 2022 -
Healthcare Partnership between Oman International Hospital and Oman Society for Petroleum Services - OPAL covers over 10.000 employees in Oman
The introductory program on OIH Advanced Health Care Services, presented to the Oman Society for Petroleum Services - OPAL was aimed to strengthen the commitment of both institutions to the continuous improvement of employees’ health and well-being.
Read moreOctober 29, 2022 -
IGHS had the pleasure to welcome SanderStrothmann in Coimbra
The IGHS Group, through its subsidiary INNOV-CELL THERAPEUTICS, has been focused on the development of innovative biotechnological-based therapeutic solutions in the dermatological sector.
This week we had the pleasure to welcome in Coimbra some elements of the german multinational company SanderStrothmann GmbH.Read moreOctober 13, 2022 -
Oman International Hospital successfully performed pediatric cornea transplant
A multidisciplinary medical team, led by Dr. Ahmed Al-Maskari, senior consultant cornea, cataract, and refractive surgeon at Oman International Hospital, used the latest model of the Femtosecond laser Femto LDV (manufactured by Swiss company Ziemer Ophthalmic Systems) to ensure a safe and efficient procedure on the 4-year-old boy.
Read moreOctober 11, 2022 -
IGHS Group and Consult Invest celebrate a contract for Central Asian Countries.
The IGHS signed today, in Tashkent, Uzbekistan, a contract with the multinational Consult Invest, for the representation of services and products of Idealmed GHS and its brand new biothech company, Innov-Cell Therapeutics, for the Central Asian Countries.
Read moreSeptember 21, 2022